Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01670201 · ClinicalTrials.gov registry record · NA
An Investigation to Evaluate a New Donor Site Dressing in Surgical Burn Patients
A NA study, sponsored by Molnlycke Health Care AB.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01670201 is a NA study that has completed, run by Molnlycke Health Care AB. The registered enrollment target is 8 participants.
The verdict
NCT01670201, a NA study, has completed, sponsored by Molnlycke Health Care AB.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The investigator will identify the test donor site and test location will be considered on the upper anterior thighs as being the most suitable if available. Circumferential donors will be considered acceptable as well. Treatment will be initiated in the operation room following debridement and split thickness grafting of wounds. Donors will be harvested at 0.010 - 0.012 in. thickness. Treatment and dressing of test donor site will include hemostasis post harvesting with epinephrine-soaked lap sponges. Once adequate hemostasis is achieved, a Mepilex Transfer Ag dressing will be applied directly to study site. Secondary dressing will include covering with ace wrap. Healing should be asses after 10-14 days.
Interventions
- DEVICE Mepilex Transfer Ag
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01670201
The ClinicalTrials.gov registry entry for NCT01670201 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Molnlycke Health Care AB, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mepilex Transfer Ag is the first listed.
NCT01670201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01670201 about?
NCT01670201 is a clinical study titled "An Investigation to Evaluate a New Donor Site Dressing in Surgical Burn Patients". The investigator will identify the test donor site and test location will be considered on the upper anterior thighs as being the most suitable if available. Circumferential donors will be considered acceptable as well. Treatment will be initiated in the operation room following debridement and spl...
What is the current status of trial NCT01670201?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2012-09. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01670201?
The interventions under investigation include: Mepilex Transfer Ag (DEVICE).
Who is sponsoring clinical trial NCT01670201?
This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.